





































































































Various	hypotheses	have	been	 formulated	 to	 explain	 this	 phenomenon,	with	 the	hygiene	hypothesis	 and	diet	 hypotheses	 attracting	 the	most	 attention.2,3	Reduced	exposure	 to	 environmental	microorganisms	and







































































filtered	again	with	VSEARCH	fastq	_filter.	Reads	were	dereplicated	(-minuniquesize	2),	clustered	at	0.97	 identity,	and	chimera	 filtered	with	VSEARCH.44	Filtered	reads	were	 then	mapped	back	 to	 the	 final	clusters	with	VSEARCH
—usearch_global.	The	resulting	operational	taxonomic	unit	(OTU)	table	was	normalized	by	using	total	DNA	extraction	yields,	and	samples	with	low	output	values	were	excluded	from	the	analysis.	Representative	sequences	(centroids)
from	each	cluster	were	classified	with	SINA	against	the	SILVA_132_NR99	database,45	and	composition	was	explored	by	using	PHINCH.46	Differences	between	treatments	were	detected	with	the	Welch	2-sided	test,	and	significantly









































































































Here	we	 demonstrate	 that	 high	 dietary	 fat	 intake	 enhances	 food	 allergy.	 Although	HFD	 feeding	 had	 no	 effect	 on	 intestinal	mast	 cells	 at	 steady	 state,	 induction	 of	 allergic	 inflammation	 in	 this	 setting	 resulted	 in	 robust
accumulation	of	mucosal	mast	cells,	which	has	previously	been	shown	to	correlate	with	disease	severity.37	However,	the	mechanisms	by	which	mast	cells	expand	in	the	setting	of	HFD	feeding	and	food	allergy	remain	poorly	defined.
Previous	studies	suggested	white	adipose	tissue	(WAT)	as	a	dedicated	reservoir	of	mast	cell	progenitors	(MCps)	that	have	the	capacity	to	migrate	to	distant	organs,	such	as	the	intestine.62	Although	HFD	feeding	in	our	experimental










Consistent	with	 previous	 reports,	HFD	 feeding	 in	 our	 experimental	 settings	was	 associated	with	 a	 significant	 decrease	 in	 α-diversity,	with	 increased	 relative	 abundance	 of	 specific	 phylotypes,	 including	 Verrucomicrobia,
Deltaproteobacteria,	Ruminococcus,	Lachnospiraceae	(Clostridia),	and	other	Bacteroidaceae.27,57	Although	HFD	feeding	has	been	demonstrated	to	promote	significant	changes	to	the	gut	microbial	community	structure	within	a	few





In	addition	 to	 identifying	 that	HFD	promotes	 intestinal	dysbiosis,	we	 found	 that	 transfer	of	an	HFD-specific	microbiota	also	conferred	enhanced	susceptibility	of	 food	allergy	 in	microbiota	 replete	GF	mice.	Strikingly,	 this
process	occurred	independently	of	any	signs	of	adiposity	in	recipient	mice.	These	findings	strongly	suggest	that	dietary	alteration	alone	is	sufficient	to	drive	microbiota-dependent	effects	on	the	intestinal	immune	system	independently
of	host	metabolic	derangement.	 It	 is	 important	to	note	that	studies	by	Turnbaugh	et	al17,18	 reported	that	 transplantation	of	a	Western	diet–associated	gut	microbiome	 into	GF	mice	 increased	total	body	fat	and	resulted	 in	signs	of





with	 food	allergy	colonized	with	an	HFD-associated	microbiome	compared	with	control	mice	 (see	Fig	E7	 in	 this	article's	Online	Repository	at	www.jacionline.org).	 It	 is	 likely	 that	 intestinal	barrier	 integrity	 in	 response	 to	a	HFD-
associated	microbiome	is	transiently	regulated,	and	therefore	no	significant	alterations	at	the	assessed	time	points	are	observed.	Alternatively,	increased	allergy	susceptibility	in	HFD	microbiota–replete	GF	mice	might	not	be	directly
related	to	alterations	in	intestinal	barrier	integrity.	Additional	studies	are	required	to	assess	a	correlation	between	food	allergy	susceptibility	and	intestinal	barrier	function	in	response	to	an	HFD-associated	microbiome.
Although	the	microbial	community	structure	in	recipient	GF	mice	differed	between	experiments,	 likely	because	of	 individual	donor	microbiomes,	 increased	susceptibility	to	experimental	food	allergy	was	conserved	in	HFD
microbiota–replete	GF	mice	across	experiments.	Although	we	 find	differences	 in	 total	OTU	numbers	between	experimental	 replicates	as	a	 likely	 result	of	differences	 in	 survival	of	 reinoculated	bacteria,	a	uniform	pattern	 toward
recovery	 of	 the	 community	 structure	 is	 observed	 across	 experiments.	 After	 comparing	 results	 from	 individual	 microbiota	 transplantation	 experiments,	 we	 consistently	 identified	members	 of	 the	 family	 Lachnospiraceae	 and	 the
Rikenellaceae	 RC9	 groups	 to	 be	 overrepresented	 in	microbiota	 replete	GF	mice	 colonized	with	 an	HFD-associated	 gut	microbiome,	whereas	members	 of	 the	 family	Muribaculaceae	 and	 the	 Prevotellaceae	 group	UCG-001	were
underrepresented	compared	with	control	mice.	Although	it	is	tempting	to	propose	individual	roles	for	OTUs,	it	is	likely	that	the	differential	effect	over	the	immune	system	varies	between	strains	and	that	the	same	response	can	be
caused	by	different	 strains	 from	different	 taxonomic	backgrounds.	Alternatively,	a	decrease	 in	overall	microbial	diversity	as	a	 result	of	prolonged	high-fat	dieting	 rather	 than	overrepresentation	or	underrepresentation	of	 specific
bacterial	strains	might	be	sufficient	to	favor	allergic	inflammation.	Consistent	with	this	hypothesis,	GF	mice	or	mice	harboring	a	reduced	gut	microbial	community	structure	(eg,	ASF	mice,	antibiotic	treated	mice)	are	more	susceptible
to	allergic	inflammation.	Importantly,	restoration	of	gut	microbial	complexity	has	proved	sufficient	to	limit	hyper-IgE	responses	and	allergic	inflammation.15,63,64	However,	it	remains	to	be	tested	whether	restoring	an	HFD-mediated
decrease	 in	microbial	 diversity	with	 fecal	microbiota	 transplants	 from	control	 diet–fed	donors	 or	 by	 reconstitution	with	 selected	microbial	 strains	might	 alter	 food	 allergy	 susceptibility.	Despite	 the	profound	effect	 of	 diet	 on	gut
bacterial	 community	 structure,	 future	 work	 should	 also	 track	 changes	 in	 interkingdom	 relationships	 on	 dietary	 manipulations	 because	 disruption	 of	 the	 mycobiome	 has	 been	 associated	 with	 increased	 susceptibility	 to	 allergic
inflammation.69,70
In	conclusion,	our	study	identifies	HFD-induced	microbial	alterations	as	a	risk	factor	for	experimental	food	allergy	and	uncouples	a	pathogenic	role	of	an	HFD-associated	microbiome	from	obesity.	Restoring	microbial	diversity
in	children	on	a	Western	diet	might	represent	a	promising	approach	to	limit	allergy	susceptibility	in	genetically	predisposed	subjects.
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Appendix
Fig	E1	Assessment	of	diet-induced	obesity.	A,	Percentage	weight	gain	in	response	to	HFD	feeding	over	time.	B,	Body	weight.	C,	Weight	of	epididymal	fat	pads.	D,	Fasting	blood	glucose	levels.	Data	are	representative	of	4	independent	experiments	with	4	to
6	mice	per	group.	Error	bars	indicate	means	±	SEMs.	*P	<	.05,	**P	<	.01,	***P	<	.005,	and	****P	<	.001.
Fig	E2	Food	allergy	induction	in	mice	fed	an	HFD	or	a	matched	control	diet.	A,	Experimental	protocol.	i.g.,	Intragastric.	B,	Clinical	allergy	score	of	control	mice	and	mice	with	food	allergy	fed	a	matched	control	diet	or	an	HFD.	C,	Serum	MMCP-1	levels.
Data	are	representative	of	2	independent	experiments	with	4	to	5	mice	per	group.	Solid	bars	represent	mice	fed	a	matched	control	diet,	and	open	bars	represent	HFD-fed	mice.	Error	bars	indicate	means	±	SEMs.	ND,	No	disease.	**P	<	.01	and	***P	<	.005.
Fig	E3	Changes	in	gut	microbial	community	structure	in	response	to	an	HFD.	A,	Bacterial	relative	abundances	represented	at	the	family	level.	B,	OTUs	that	show	significant	differences	in	abundance	across	treatments,	according	to	the	Welch	2-sided	test.
OTUs	shown	all	have	P	values	of	less	than	.05	(corrected	with	the	Storey	false	discovery	rate)	and	large	effect	sizes	(differences	between	proportions	>	1	and	ratios	between	proportions	>	2).	FA,	▪▪▪food	allergy.
Fig	E4	Changes	in	gut	microbial	community	structure	at	the	OTU,	genus,	and	family	levels	in	microbiota-replete	GF	mice,	according	to	the	Welch	2-sided	test.	Only	differences	with	large	effect	sizes	(differences	between	proportions	>	1	and	ratios	between
proportions	>	2)	are	shown.
Fig	E5	An	HFD-associated	microbiome	does	not	promote	weight	gain.	A,	Percentage	body	weight	gain	of	GF	mice	reconstituted	with	an	SCD-	or	HFD-associated	microbiome.	B,	Body	weight.	C,	Weight	of	epididymal	fat	pads.	Data	are	representative	of	2
independent	experiments	with	4	to	5	mice	per	group.	Solid	bars	represent	GF	mice	reconstituted	with	an	SCD-associated	microbiome,	and	open	bars	represent	HFD	microbiome–reconstituted	mice.	Error	bars	indicate	means	±	SEMs.	ns,	Not	significant.
Table	E1	Description	of	clinical	allergy	score
Score Description
Scratching
 0 No	symptoms
 1 Mild	scratching;	rubbing	of	nose,	head,	or	feet	(<5	episodes)
 2 Intermediate	scratching;	rubbing	of	nose,	head,	or	feet	(>5	to	<10	episodes)
 3 Severe	scratching	(>10	episodes)
Behavior
 0 Normal
 1 Hyperactivity
 2 Aggressive	behavior;	pain	loud	after	prodding
Fig	E6	Assessment	of	MCps	in	WAT	of	SCD	or	HFD	fed	mice.	A,	Representative	flow	cytometric	plots	of	MCps	in	WAT	of	control	mice	or	mice	with	food	allergy	fed	an	SCD	or	HFD.	eWAT,	Epididymal	WAT.	B,	WAT	MCp	numbers.	Data	are	representative	of	2
individual	experiment	with	3	to	5	mice	per	group.	Error	bars	indicate	means	±	SEMs.	**P	≤	.01.
Fig	E7	Gene	expression	levels	for	intestinal	barrier–associated	genes	in	microbiome-replete	mice	with	food	allergy.	Gene	expression	levels	of	Ocln	(A),	Tjp1	(B),	and	Cldn2	(C)	in	the	small	intestines	of	microbiota-replete	GF	mice	with	food	allergy.	Data	are
representative	of	2	independent	experiments	with	4	mice	per	group.	Solid	bars	represent	GF	mice	with	food	allergy	reconstituted	with	an	SCD-associated	microbiome,	and	open	bars	represent	HFD	microbiome–reconstituted	mice	with	food	allergy.	Error
bars	indicate	means	±	SEMs.
Queries	and	Answers
Query:	If	there	are	any	drug	dosages	in	your	article,	please	verify	them	and	indicate	that	you	have	done	so	by	initialing	this	query
Answer:	does	not	apply
Query:	Please	verify	that	WAT	is	spelled	out	correctly	here	as	“white	adipose	tissue.”
Answer:	correct
Query:	Please	clarify	the	“Kit	protocol.”	Should	this	have	a	citation	or	manufacturer’s	information?
Answer:	QIAmp	Fast	DNA	Stool	Kit,	Qiagen
Query:	Please	verify	that	data	on	quality	filtering	of	raw	reads	is	presented	clearly	and	completely	as	shown	(ie,	please	spell	out	“-p,”	“-m,”	etc).	Also,	if	applicable,	please	provide	a	citation	for	Zhang
et	al,	citing	it	in	numeric	order	and	renumbering	all	subsequent	citations	throughout.
Answer:	Raw	reads	were	quality-filtered	with	FastX-Tookit	(a	minimum	quality	score	of	33	kept	across	75%	of	the	bases),	merged	with	PEAR	(with	a	maximum	possible	length	of	merged	reads	of	360,
minimum	possible	length	of	merged	reads	of	100,	score	quality	threshold	for	trimming	of	26,	minimum	overlap	size	of	50,	and	a	base	PHRED	quality	score	of	33
Query:	Please	spell	out	ADONIS	and	ANOSIM	throughout,	if	applicable.
Answer:	These	are	standard	statistical	tests!
Query:	Please	note	that	P	values	indicated	by	asterisks	have	been	moved	to	figure	legends	per	journal	style.	Please	check	carefully.
Answer:	ok
Physical	appearance
 0 Normal	activity
 2 Significantly	reduced	mobility;	piloerection
 3 Immobility	after	prodding,	tremors,	and/or	significant	respiratory	distress
Stool	consistency
 0 Normal
 2 Loose	stool
 4 Diarrhea
Graphical	abstract
Query:	Please	provide	volume	number	for	reference	46.
Answer:	No	volume	number	found	either!
Query:	Please	provide	volume	and	page	numbers	for	reference	56.	It	does	not	appear	in	PubMed.
Answer:	Reference	replaced
Query:	Please	spell	out	FA	in	the	legend	fir	Fig	E3.
Answer:	FA:	food	allergy
Query:	Have	we	correctly	interpreted	the	following	funding	source(s)	and	country	names	you	cited	in	your	article:	Human	Frontier	Science	Program,	France;	Fondation	Acteria,	Switzerland;	European
Research	Council,	European	Union?
Answer:	Yes
Query:	Please	confirm	that	given	names	and	surnames	have	been	identified	correctly	and	are	presented	in	the	desired	order	and	please	carefully	verify	the	spelling	of	all	authors’	names.
Answer:	Yes
